William S Phipps1, Dina N Greene1, Hannah Pflaum1, Thomas J Laha1, Jane A Dickerson2, Jill Irvine3, Anna E Merrill1, Pratistha Ranjitkar1, Clark M Henderson1, Andrew N Hoofnagle4. 1. Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States. 2. Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States; Seattle Children's Hospital, Seattle, WA, United States. 3. University of Washington Medical Center, Seattle, WA, United States. 4. Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States; Department of Medicine, University of Washington, Seattle, WA, United States. Electronic address: ahoof@uw.edu.
Abstract
BACKGROUND: The measurement of plasma concentrations of retinol binding protein is a component of nutritional assessment in neonatal intensive care. However, serial testing in newborns is hampered by the limited amount of blood that can be sampled. Limitations are most severe with preterm infants, for whom close monitoring may be most important. METHODS: We developed an assay to quantify retinol binding protein using trypsin digestion and liquid chromatography-tandem mass spectrometry, which requires a serum or plasma volume of 5 µl. Additionally, we validated the method according to current recommendations and performed comparison with a standard nephelometry platform in clinical use. RESULTS: The assay demonstrated linearity from below 1 mg/dL (0.48 µM) to more than 20 mg/dL (9.7 µM), and an imprecision of 11.8% at 0.43 mg/dL (0.21 µM). The distribution of results observed with the new method was different when compared with nephelometry. CONCLUSION: Liquid chromatography-tandem mass spectrometry facilitated testing a smaller sample volume, thereby increasing the ability to monitor key nutritional markers in premature infants. The differences in results compared with a commercially-available nephelometric assay revealed questionable results for lower concentrations by immunoassay.
BACKGROUND: The measurement of plasma concentrations of retinol binding protein is a component of nutritional assessment in neonatal intensive care. However, serial testing in newborns is hampered by the limited amount of blood that can be sampled. Limitations are most severe with preterm infants, for whom close monitoring may be most important. METHODS: We developed an assay to quantify retinol binding protein using trypsin digestion and liquid chromatography-tandem mass spectrometry, which requires a serum or plasma volume of 5 µl. Additionally, we validated the method according to current recommendations and performed comparison with a standard nephelometry platform in clinical use. RESULTS: The assay demonstrated linearity from below 1 mg/dL (0.48 µM) to more than 20 mg/dL (9.7 µM), and an imprecision of 11.8% at 0.43 mg/dL (0.21 µM). The distribution of results observed with the new method was different when compared with nephelometry. CONCLUSION: Liquid chromatography-tandem mass spectrometry facilitated testing a smaller sample volume, thereby increasing the ability to monitor key nutritional markers in premature infants. The differences in results compared with a commercially-available nephelometric assay revealed questionable results for lower concentrations by immunoassay.
Authors: Brendan Maclean; Daniela M Tomazela; Susan E Abbatiello; Shucha Zhang; Jeffrey R Whiteaker; Amanda G Paulovich; Steven A Carr; Michael J Maccoss Journal: Anal Chem Date: 2010-11-19 Impact factor: 6.986
Authors: F Kanakoudi; V Drossou; V Tzimouli; E Diamanti; T Konstantinidis; A Germenis; G Kremenopoulos Journal: Clin Chem Date: 1995-04 Impact factor: 8.327
Authors: Young Min Cho; Byung-Soo Youn; Hyewon Lee; Namseok Lee; Sung-Shik Min; Soo Heon Kwak; Hong Kyu Lee; Kyong Soo Park Journal: Diabetes Care Date: 2006-11 Impact factor: 19.112
Authors: Vagisha Sharma; Josh Eckels; Greg K Taylor; Nicholas J Shulman; Andrew B Stergachis; Shannon A Joyner; Ping Yan; Jeffrey R Whiteaker; Goran N Halusa; Birgit Schilling; Bradford W Gibson; Christopher M Colangelo; Amanda G Paulovich; Steven A Carr; Jacob D Jaffe; Michael J MacCoss; Brendan MacLean Journal: J Proteome Res Date: 2014-08-18 Impact factor: 4.466